Abstract
The analysis of positive and negative standards measurements for a large clinical trial employing fluorescence and reflectance spectroscopy shows that a well designed set of standards and frequent measurement should be an essential component of any optical device clinical trial.
© 2004 Optical Society of America
PDF ArticleMore Like This
A.K. Dattamajumdar, D. Wells, J. Parnell, D. Ganguly, and T.C. Wright
4432_312 European Conference on Biomedical Optics (ECBO) 2001
David Nolte, Ran An, and John Turek
EW1C.4 European Conference on Biomedical Optics (ECBO) 2021
Changfang Zhu, Elizabeth Burnside, Gale Sisney, Josephine Harter, and Nirmala Ramanujam
TuD9 Biomedical Topical Meeting (BIOMED) 2006